Encapsulated Papillary Carcinoma: A Rare Case Report and Its Imaging Features.

Diagnostics (Basel)

Department of Surgery, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras, Kuala Lumpur 56000, Malaysia.

Published: August 2022

Papillary lesions in the breasts are uncommon and have a wide range of pathologies. Due to diverse non-specific findings radiologically and histologically, papillary neoplasms are always a challenge to radiologists. Encapsulated papillary carcinomas (EPCs) of the breast, also known as intracystic papillary carcinomas, are a subgroup of intraductal papillary lesions of the breast. We present a case of a painless right breast lump with the aim to describe a rare encapsulated papillary carcinoma and its imaging features.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497607PMC
http://dx.doi.org/10.3390/diagnostics12092098DOI Listing

Publication Analysis

Top Keywords

encapsulated papillary
12
papillary carcinoma
8
imaging features
8
papillary lesions
8
papillary carcinomas
8
papillary
6
carcinoma rare
4
rare case
4
case report
4
report imaging
4

Similar Publications

In recent years, germline mutations in the microRNA (miRNA) processor genes DICER1 and DGCR8 have been coupled to the development of thyroid follicular nodular disease (TFND), thereby casting new light on the etiology of this enigmatic, benign condition in non-iodine-deficient regions. Moreover, DICER1 and DGCR8 mutations have also been reported in rare subsets of follicular cell-derived thyroid carcinomas. Specifically, truncating germline or missense somatic DICER1 mutations have been reported in small subsets of pediatric and adolescent follicular thyroid carcinoma (FTC) and poorly differentiated thyroid carcinoma (PDTC).

View Article and Find Full Text PDF

We report encapsulated papillary carcinoma and mucinous carcinoma in a case of local advanced bilateral breast cancer. The patient was 78-year-old woman who had bilateral breast tumor. The right palpable tumor was 6 cm in diameter and left tumor was 7 cm in a diameter.

View Article and Find Full Text PDF
Article Synopsis
  • Primary cardiac tumors (PCTs) like myxomas and lipomas are rare, with lipomas being soft fat masses that can lead to diagnostic challenges.
  • Lipomatous hypertrophy of the atrial septum (LHAS) is a benign condition linked to aging and obesity, distinct from true cardiac lipomas.
  • A case of a true atrial septal lipoma discovered during heart dissection is detailed, highlighting its potential effects on heart function and contributing to the scarce literature on benign primary cardiac tumors.
View Article and Find Full Text PDF

Granulomatous mastitis forming a well-defined large mass diagnosed by surgical excision: a case report.

Surg Case Rep

November 2024

Department of Breast Oncology, Faculty of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-Ku, Tokyo, 113-0033, Japan.

Background: Granulomatous mastitis is a relatively rare benign inflammatory disease of the breast, but it is sometimes difficult to distinguish from breast cancer by imaging. We experienced a case that was definitively diagnosed as granulomatous mastitis from the surgical specimen. The mass appeared as a large cystic lesion on imaging, which is unusual for granulomatous mastitis, and was initially suspected to be an encapsulated papillary carcinoma.

View Article and Find Full Text PDF

Encapsulated papillary carcinoma (EPC) represents a distinct entity within the spectrum of breast papillary tumors, typically manifesting as a retroareolar mass. This rare subtype can be effectively visualized using ultrasound and magnetic resonance imaging, which reveal characteristic cystic-solid nodules. Histopathologically, EPC is defined by a papillary tumor structure with a well-defined fibrous capsule, devoid of myoepithelial cells both within and around the capsule.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!